# Progesterone in the Treatment of Acute Hemorrhagic Stroke

> **NCT04143880** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 184 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Progesterone
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT04143880
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2019-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143880, "Progesterone in the Treatment of Acute Hemorrhagic Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04143880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*